Medication Considerations

This Advisory outlines how healthcare providers (i.e., obstetrician-gynecologists [OB-GYNs], primary care physicians, and other professionals who treat pregnant people) can take an active role in supporting the health of pregnant individuals who have OUD and their babies.

This Quick Take outlines the legal and policy efforts that have led to an increase in availability and stresses the importance of continued advocacy efforts to further expand MOUD availability in jails and prisons and in the community.

This NIDA web page includes facts and figures on addressing substance use disorders in the prison population.

This NIDA web page includes facts and figures on prescription opioids.

This two-page pocket guide includes facts and a checklist for all practitioners seeking to prescribe buprenorphine.

This quick start guide includes facts and a checklist for all practitioners seeking to prescribe buprenorphine.

This toolkit provides guidance and information to hospitals and health systems on how they can partner with patients, clinicians and communities to address the opioid epidemic.

This fact sheet includes basic descriptions of medications for opioid use disorders (MOUD) including naltrexone, buprenorphine, and methadone. It also addresses how MOUD can help those struggling with opioid use disorder, misunderstandings about MOUD, and additional considerations.

This fact sheet includes a basic description of opioids, a brief explanation of the risks, ways to prevent misuse, and strategies to helped loved ones who may be struggling with substance use disorder.

This web page provides frequently asked questions for rules on prescribing buprenorphine and other and other medications for opioid use disorder (MOUD), following 2023 policy updates.